If ever there was a celebrity in health care, it was Dr. Atul Gawande. He frequented the biggest stages in media and medicine. He gave TED talks, interviews with top journalists, and moderated a discussion on health innovation with President Obama. His books and essays for the New Yorker made him not just a sought-after speaker, but the unofficial leader of medicine’s less-is-more movement.

At least, until six months ago, when he became a CEO. Since drawing tremendous attention when he was dispatched by the leaders of Amazon, JPMorgan Chase, and Berkshire Hathaway to create a venture with the long-term goal of transforming health care, Gawande has virtually disappeared from the public eye. He isn’t giving interviews or releasing information about the direction of the new company.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I bet the good doctor is still scrubbing, trying to get the stench of those vultures off of himself. They attempted to use his good name and crediblity to market their new data collection products, and misinform the public. In Post Fact America, every media outlet covered this story, in an attempt to make this weoponized data collection, more benign. The “news” won’t be covering his actual response to being used, manipulated, and tricked into becoming a mascot for a slow genocide.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy